Global Choroidal Neovascularization Market Research Report 2023

Choroidal Neovascularization Market

Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.

According to new survey, global Choroidal Neovascularization market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Choroidal Neovascularization market research.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Choroidal Neovascularization market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Choroidal Neovascularization Market Report

1.1 Product Overview and Scope of Choroidal Neovascularization

1.2 Choroidal Neovascularization Segment by Type

1.2.1 Global Choroidal Neovascularization Market Value Comparison by Type (2023-2029)

1.2.2 Intravenous

1.2.3 Intravitreal

1.3 Choroidal Neovascularization Segment by Application

1.3.1 Global Choroidal Neovascularization Market Value by Application: (2023-2029)

1.3.2 Extreme Myopia

1.3.3 Malignant Myopic Degeneration

1.3.4 Age-Related Developments

1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts

1.4.1 Global Choroidal Neovascularization Revenue 2018-2029

1.4.2 Global Choroidal Neovascularization Sales 2018-2029

1.4.3 Global Choroidal Neovascularization Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2018-2023)

2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2018-2023)

2.4 Global Choroidal Neovascularization Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application

2.7 Choroidal Neovascularization Market Competitive Situation and Trends

2.7.1 Choroidal Neovascularization Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue

2.7.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Choroidal Neovascularization Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Choroidal Neovascularization Global Choroidal Neovascularization Sales by Region: 2018-2029

3.2.1 Global Choroidal Neovascularization Sales by Region: 2018-2023

3.2.2 Global Choroidal Neovascularization Sales by Region: 2024-2029

3.3 Global Choroidal Neovascularization Global Choroidal Neovascularization Revenue by Region: 2018-2029

3.3.1 Global Choroidal Neovascularization Revenue by Region: 2018-2023

3.3.2 Global Choroidal Neovascularization Revenue by Region: 2024-2029

3.4 North America Choroidal Neovascularization Market Facts & Figures by Country

3.4.1 North America Choroidal Neovascularization Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Choroidal Neovascularization Sales by Country (2018-2029)

3.4.3 North America Choroidal Neovascularization Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.4.6 Mexico

3.5 Europe Choroidal Neovascularization Market Facts & Figures by Country

3.5.1 Europe Choroidal Neovascularization Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Choroidal Neovascularization Sales by Country (2018-2029)

3.5.3 Europe Choroidal Neovascularization Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Country

3.6.1 Asia Pacific Choroidal Neovascularization Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Choroidal Neovascularization Sales by Country (2018-2029)

3.6.3 Asia Pacific Choroidal Neovascularization Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Indonesia

3.6.10 Thailand

3.6.11 Malaysia

3.6.12 Philippines

3.6.13 Vietnam

3.7 Latin America Choroidal Neovascularization Market Facts & Figures by Country

3.7.1 Latin America Choroidal Neovascularization Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Choroidal Neovascularization Sales by Country (2018-2029)

3.7.3 Latin America Choroidal Neovascularization Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country

3.8.1 Middle East and Africa Choroidal Neovascularization Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Choroidal Neovascularization Sales by Country (2018-2029)

3.8.3 Middle East and Africa Choroidal Neovascularization Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Choroidal Neovascularization Sales by Type (2018-2029)

4.1.1 Global Choroidal Neovascularization Sales by Type (2018-2023)

4.1.2 Global Choroidal Neovascularization Sales by Type (2024-2029)

4.1.3 Global Choroidal Neovascularization Sales Market Share by Type (2018-2029)

4.2 Global Choroidal Neovascularization Revenue by Type (2018-2029)

4.2.1 Global Choroidal Neovascularization Revenue by Type (2018-2023)

4.2.2 Global Choroidal Neovascularization Revenue by Type (2024-2029)

4.2.3 Global Choroidal Neovascularization Revenue Market Share by Type (2018-2029)

4.3 Global Choroidal Neovascularization Price by Type (2018-2029)

5.1 Global Choroidal Neovascularization Sales by Application (2018-2029)

5.1.1 Global Choroidal Neovascularization Sales by Application (2018-2023)

5.1.2 Global Choroidal Neovascularization Sales by Application (2024-2029)

5.1.3 Global Choroidal Neovascularization Sales Market Share by Application (2018-2029)

5.2 Global Choroidal Neovascularization Revenue by Application (2018-2029)

5.2.1 Global Choroidal Neovascularization Revenue by Application (2018-2023)

5.2.2 Global Choroidal Neovascularization Revenue by Application (2024-2029)

5.2.3 Global Choroidal Neovascularization Revenue Market Share by Application (2018-2029)

5.3 Global Choroidal Neovascularization Price by Application (2018-2029)

6.1 Pfizer Inc.

6.1.1 Pfizer Inc. Corporation Information

6.1.2 Pfizer Inc. Description and Business Overview

6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pfizer Inc. Choroidal Neovascularization Product Portfolio

6.1.5 Pfizer Inc. Recent Developments/Updates

6.2 F. Hoffmann-La Roche Ltd.

6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information

6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview

6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolio

6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Corporation Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Novartis AG Choroidal Neovascularization Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Regeneron Pharmaceuticals Inc.

6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information

6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview

6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolio

6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates

6.5 Bayer AG

6.5.1 Bayer AG Corporation Information

6.5.2 Bayer AG Description and Business Overview

6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Bayer AG Choroidal Neovascularization Product Portfolio

6.5.5 Bayer AG Recent Developments/Updates

6.6 QLT Inc.

6.6.1 QLT Inc. Corporation Information

6.6.2 QLT Inc. Description and Business Overview

6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.6.4 QLT Inc. Choroidal Neovascularization Product Portfolio

6.6.5 QLT Inc. Recent Developments/Updates

6.7 Sanwa Kagaku Kenkyusho Co. Ltd.

6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information

6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview

6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolio

6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates

6.8 Promedior Inc.

6.8.1 Promedior Inc. Corporation Information

6.8.2 Promedior Inc. Description and Business Overview

6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Promedior Inc. Choroidal Neovascularization Product Portfolio

6.8.5 Promedior Inc. Recent Developments/Updates

6.9 Bausch Health

6.9.1 Bausch Health Corporation Information

6.9.2 Bausch Health Description and Business Overview

6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Bausch Health Choroidal Neovascularization Product Portfolio

6.9.5 Bausch Health Recent Developments/Updates

6.10 Gilead Sciences Inc

6.10.1 Gilead Sciences Inc Corporation Information

6.10.2 Gilead Sciences Inc Description and Business Overview

6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Gilead Sciences Inc Choroidal Neovascularization Product Portfolio

6.10.5 Gilead Sciences Inc Recent Developments/Updates

7.1 Choroidal Neovascularization Industry Chain Analysis

7.2 Choroidal Neovascularization Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Choroidal Neovascularization Production Mode & Process

7.4 Choroidal Neovascularization Sales and Marketing

7.4.1 Choroidal Neovascularization Sales Channels

7.4.2 Choroidal Neovascularization Distributors

7.5 Choroidal Neovascularization Customers

8.1 Choroidal Neovascularization Industry Trends

8.2 Choroidal Neovascularization Market Drivers

8.3 Choroidal Neovascularization Market Challenges

8.4 Choroidal Neovascularization Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Choroidal Neovascularization Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Choroidal Neovascularization Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Choroidal Neovascularization Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Choroidal Neovascularization Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Choroidal Neovascularization Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Choroidal Neovascularization Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Choroidal Neovascularization, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application

    Table 12. Global Key Manufacturers of Choroidal Neovascularization, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)

    Table 18. Global Choroidal Neovascularization Sales Market Share by Region (2018-2023)

    Table 19. Global Choroidal Neovascularization Sales by Region (2024-2029) & (K Units)

    Table 20. Global Choroidal Neovascularization Sales Market Share by Region (2024-2029)

    Table 21. Global Choroidal Neovascularization Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Choroidal Neovascularization Revenue Market Share by Region (2018-2023)

    Table 23. Global Choroidal Neovascularization Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Choroidal Neovascularization Revenue Market Share by Region (2024-2029)

    Table 25. North America Choroidal Neovascularization Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)

    Table 27. North America Choroidal Neovascularization Sales by Country (2024-2029) & (K Units)

    Table 28. North America Choroidal Neovascularization Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Choroidal Neovascularization Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Choroidal Neovascularization Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Choroidal Neovascularization Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Choroidal Neovascularization Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Choroidal Neovascularization Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Choroidal Neovascularization Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Choroidal Neovascularization Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Choroidal Neovascularization Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Choroidal Neovascularization Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Choroidal Neovascularization Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Choroidal Neovascularization Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Choroidal Neovascularization Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Choroidal Neovascularization Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Choroidal Neovascularization Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Choroidal Neovascularization Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Choroidal Neovascularization Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Choroidal Neovascularization Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Choroidal Neovascularization Sales (K Units) by Type (2018-2023)

    Table 51. Global Choroidal Neovascularization Sales (K Units) by Type (2024-2029)

    Table 52. Global Choroidal Neovascularization Sales Market Share by Type (2018-2023)

    Table 53. Global Choroidal Neovascularization Sales Market Share by Type (2024-2029)

    Table 54. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Choroidal Neovascularization Revenue Market Share by Type (2018-2023)

    Table 57. Global Choroidal Neovascularization Revenue Market Share by Type (2024-2029)

    Table 58. Global Choroidal Neovascularization Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Choroidal Neovascularization Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Choroidal Neovascularization Sales (K Units) by Application (2018-2023)

    Table 61. Global Choroidal Neovascularization Sales (K Units) by Application (2024-2029)

    Table 62. Global Choroidal Neovascularization Sales Market Share by Application (2018-2023)

    Table 63. Global Choroidal Neovascularization Sales Market Share by Application (2024-2029)

    Table 64. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Choroidal Neovascularization Revenue Market Share by Application (2018-2023)

    Table 67. Global Choroidal Neovascularization Revenue Market Share by Application (2024-2029)

    Table 68. Global Choroidal Neovascularization Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Choroidal Neovascularization Price (USD/Unit) by Application (2024-2029)

    Table 70. Pfizer Inc. Corporation Information

    Table 71. Pfizer Inc. Description and Business Overview

    Table 72. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Pfizer Inc. Choroidal Neovascularization Product

    Table 74. Pfizer Inc. Recent Developments/Updates

    Table 75. F. Hoffmann-La Roche Ltd. Corporation Information

    Table 76. F. Hoffmann-La Roche Ltd. Description and Business Overview

    Table 77. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product

    Table 79. F. Hoffmann-La Roche Ltd. Recent Developments/Updates

    Table 80. Novartis AG Corporation Information

    Table 81. Novartis AG Description and Business Overview

    Table 82. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Novartis AG Choroidal Neovascularization Product

    Table 84. Novartis AG Recent Developments/Updates

    Table 85. Regeneron Pharmaceuticals Inc. Corporation Information

    Table 86. Regeneron Pharmaceuticals Inc. Description and Business Overview

    Table 87. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product

    Table 89. Regeneron Pharmaceuticals Inc. Recent Developments/Updates

    Table 90. Bayer AG Corporation Information

    Table 91. Bayer AG Description and Business Overview

    Table 92. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Bayer AG Choroidal Neovascularization Product

    Table 94. Bayer AG Recent Developments/Updates

    Table 95. QLT Inc. Corporation Information

    Table 96. QLT Inc. Description and Business Overview

    Table 97. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. QLT Inc. Choroidal Neovascularization Product

    Table 99. QLT Inc. Recent Developments/Updates

    Table 100. Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information

    Table 101. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview

    Table 102. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product

    Table 104. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates

    Table 105. Promedior Inc. Corporation Information

    Table 106. Promedior Inc. Description and Business Overview

    Table 107. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Promedior Inc. Choroidal Neovascularization Product

    Table 109. Promedior Inc. Recent Developments/Updates

    Table 110. Bausch Health Corporation Information

    Table 111. Bausch Health Description and Business Overview

    Table 112. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Bausch Health Choroidal Neovascularization Product

    Table 114. Bausch Health Recent Developments/Updates

    Table 115. Gilead Sciences Inc Corporation Information

    Table 116. Gilead Sciences Inc Description and Business Overview

    Table 117. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Gilead Sciences Inc Choroidal Neovascularization Product

    Table 119. Gilead Sciences Inc Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Choroidal Neovascularization Distributors List

    Table 123. Choroidal Neovascularization Customers List

    Table 124. Choroidal Neovascularization Market Trends

    Table 125. Choroidal Neovascularization Market Drivers

    Table 126. Choroidal Neovascularization Market Challenges

    Table 127. Choroidal Neovascularization Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Choroidal Neovascularization

    Figure 2. Global Choroidal Neovascularization Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Choroidal Neovascularization Market Share by Type in 2022 & 2029

    Figure 4. Intravenous Product Picture

    Figure 5. Intravitreal Product Picture

    Figure 6. Global Choroidal Neovascularization Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Choroidal Neovascularization Market Share by Application in 2022 & 2029

    Figure 8. Extreme Myopia

    Figure 9. Malignant Myopic Degeneration

    Figure 10. Age-Related Developments

    Figure 11. Global Choroidal Neovascularization Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Choroidal Neovascularization Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Choroidal Neovascularization Sales (2018-2029) & (K Units)

    Figure 14. Global Choroidal Neovascularization Average Price (USD/Unit) & (2018-2029)

    Figure 15. Choroidal Neovascularization Report Years Considered

    Figure 16. Choroidal Neovascularization Sales Share by Manufacturers in 2022

    Figure 17. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Choroidal Neovascularization Players: Market Share by Revenue in 2022

    Figure 19. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Choroidal Neovascularization Sales Market Share by Country (2018-2029)

    Figure 22. North America Choroidal Neovascularization Revenue Market Share by Country (2018-2029)

    Figure 23. United States Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Mexico Choroidal Neovascularization Revenue Growth Rate (2018-2023) & (US$ Million)

    Figure 26. Europe Choroidal Neovascularization Sales Market Share by Country (2018-2029)

    Figure 27. Europe Choroidal Neovascularization Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. UK Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Choroidal Neovascularization Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Choroidal Neovascularization Revenue Market Share by Region (2018-2029)

    Figure 35. China Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Vietnam Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Choroidal Neovascularization Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Choroidal Neovascularization Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Choroidal Neovascularization Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Choroidal Neovascularization by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Choroidal Neovascularization by Type (2018-2029)

    Figure 57. Global Choroidal Neovascularization Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Choroidal Neovascularization by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Choroidal Neovascularization by Application (2018-2029)

    Figure 60. Global Choroidal Neovascularization Price (USD/Unit) by Application (2018-2029)

    Figure 61. Choroidal Neovascularization Value Chain

    Figure 62. Choroidal Neovascularization Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed